Jim Simons Neuro Sense Therapeutics Ltd. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Renaissance Technologies LLC holds 71,100 shares of NRSN stock, worth $66,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71,100Holding current value
$66,123% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding NRSN
# of Institutions
9Shares Held
167KCall Options Held
0Put Options Held
0-
Meitav Dash Investments LTD50KShares$46,5000.0% of portfolio
-
Woodline Partners LP San Francisco, CA19.6KShares$18,2100.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$11,1250.0% of portfolio
-
Ubs Group Ag11.9KShares$11,0930.0% of portfolio
-
Morgan Stanley New York, NY1.5KShares$1,3950.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $10.9M